What is Maravai LifeSciences Holdings, Inc.'s trilink — R&D?

Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — R&D of $2.52M in Q1 2026.

How has Maravai LifeSciences Holdings, Inc.'s trilink — R&D changed year-over-year?

Maravai LifeSciences Holdings, Inc.'s trilink — R&D increased by 0.9% year-over-year, from $2.5M to $2.52M.

What does trilink — R&D mean?

This represents the investment in scientific research, product innovation, and the development of new technologies within the segment. It is a leading indicator of the company's commitment to future growth and its ability to maintain a competitive edge through technological advancement.

Maravai LifeSciences Holdings, Inc. MRVI TriLink — R&D

Other segment segments

Cygnus

$483K—

Similar metrics at other companies

LITEIndustrial Tech — R&D

$15.33M-9.9%

QDELR&D

$2.3M-14.8%

ESISpecialties — R&D

$3.5M+6.1%

RDWDefense Tech — R&D

$7.91M+16,719%

BHCDiversified — R&D

$3M0.0%

ITTConnect & Control Technologies — Research and development expenses

$12.6M+51.8%

Other financials

Income statement

See full

Revenue$65.8M+40.5%

Gross profit$33.7M+336%

Operating income-$2.2M+95.6%

Net income-$3.7M+87.5%

EPS (diluted)-$0.02+90.5%

Balance sheet

See full

Cash & equivalents$165.9M-41.8%

Total debt$270.9M-17.1%

Total equity$211.6M-29.6%

Total assets$713.2M-25.7%

Cash flow

See full

Operating cash flow$8.7M+192%

CapEx$4.4M-1.4%

Free cash flow$4.2M+130%

Valuation

See full

Market cap$902.74M+204%

Enterprise value$1.01B+198%

P/S4.4×+3.2×

Profitability

See full

Gross margin29.3%-8.0pp

Operating margin-82.2%-16.6pp

Net margin-51.1%-9.9pp

FCF margin-25.7%—

Returns & leverage

See full

Return on equity-40.8%-4.0pp

Debt / equity1.3×+0.2×

Current ratio5.9×-0.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s trilink — R&D?: Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — R&D of $2.52M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s trilink — R&D changed year-over-year?: Maravai LifeSciences Holdings, Inc.'s trilink — R&D increased by 0.9% year-over-year, from $2.5M to $2.52M.
What does trilink — R&D mean?: This represents the investment in scientific research, product innovation, and the development of new technologies within the segment. It is a leading indicator of the company's commitment to future growth and its ability to maintain a competitive edge through technological advancement.